Global Stocks Mixed as Strong U.S. Jobs Data Meets Oil-Driven Inflation Fears | MarketReader Minute

Global markets traded mixed after stronger-than-expected U.S. hiring data highlighted economic resilience, while surging oil prices tied to Middle East tensions reignited inflation concerns. Rising crude and weaker bond prices fueled uncertainty over the Federal Reserve's next moves.

Welcome to the MarketReader Minute.

Below are AI-generated insights on today’s premarket moves, powered by MarketReader technology.

Wednesday, June 02

Noteworthy macro moves today: Nikkei 225 Index (Japan) +3.1%. US 10Y Treasury Bond Index -0.2%. US 2Y Treasury Bond Index -0.1%. Noteworthy US mega-cap moves today: Broadcom Inc (AVGO) +1.9%. Tesla Inc (TSLA) -1.5%. Alphabet Inc (GOOG) -1.5%.

Noteworthy macro moves today: Nikkei 225 Index (Japan) +3.1%. US 10Y Treasury Bond Index -0.3%. US 2Y Treasury Bond Index -0.1%. Noteworthy US mega-cap moves today: Broadcom Inc (AVGO) +2.1%. Tesla Inc (TSLA) -1.5%. Alphabet Inc (GOOGL) -1.3%.

Global equity indices are trading lower as concerns over inflation persist due to rising energy costs linked to ongoing geopolitical tensions in the Middle East, particularly following Iranian missile strikes and U.S.-Iran negotiations that remain unresolved, which have contributed to increased oil prices and market volatility.

In the U.S., the ADP Employment Change report released this morning showed that private sector employment rose by 122,000 jobs in May, exceeding expectations of a gain of only 117,000 jobs and indicating broad-based hiring trends across various sectors, which has led to a positive sentiment regarding labor market resilience despite inflationary pressures.
Meanwhile, U.S Treasury bond yields are rising as reflected by the decline in bond indices; this is likely driven by stronger-than-expected job growth

VanEck J. P. Morgan EM Local Currency Bond ETF (EMLC) [+1.8%]
The VanEck J. P. Morgan EM Local Currency Bond ETF is trading higher in pre-market hours, reflecting strong activity as it approaches the upper end of its one-month trading range. No specific news was identified to explain this price movement. Broader market conditions are mixed, influenced by ongoing tensions in the Middle East and rising oil prices, but these factors do not appear to directly impact the ETF's performance.

abrdn Physical Palladium Shares ETF (PALL) [-1.6%]
No specific news was identified regarding the abrdn Physical Palladium Shares ETF. In pre-market trading on Wednesday, the ETF is trading lower, reflecting broader market conditions influenced by rising oil prices and ongoing geopolitical tensions. The asset reached a session low earlier, indicating persistent weakness as it remains near the lower end of its one-month range.

MRVL | +12.2% | +515.0B
Marvell Technology Inc | Semiconductors

Marvell Technology Inc. is experiencing a notable increase in its stock price, driven by positive comments from NVIDIA's CEO, Jensen Huang, who referred to Marvell as the "next trillion-dollar company" during a keynote speech at Computex. This endorsement follows a substantial surge of 32.5% the previous day, and the stock has added another 11.7% in pre-market trading. The strong investor sentiment is reflected in trading volume, which surged to 102 million shares, significantly above its three-month average. Discussions on social media indicate bullish sentiment surrounding Marvell, fueled by expectations for AI infrastructure demand and potential revenue growth from new product offerings, such as the AI-focused Teralynx T100 switch.

APO | -5.2% | -3.6B
Apollo Global Management Inc | Diversified Financial Services

Apollo Global Management Inc. is experiencing a notable decline during pre-market hours following the completion of its sale of ALTEMIRA Holdings Co., Ltd. to MBK Partners. This divestiture marks Apollo's exit from a significant investment in the aluminum packaging sector, raising concerns among investors about the company's strategic direction. Additionally, Hilton Grand Vacations disclosed a secondary offering of 5 million shares by affiliates of Apollo, which has further contributed to apprehension regarding liquidity and potential dilution. These developments have likely influenced the negative market reaction observed today.

INTC | +6.2% | +30.4B
Intel Corp | Semiconductors

Intel Corp shares are sharply higher in pre-market trading, gaining 7.8% after five consecutive days of declines. This rebound follows comments made at the Bank of America Global Technology Conference, where Intel indicated potential adjustments to its fiscal year 2027 margin targets based on current progress. Despite ongoing challenges related to the supply of new laptop chips, including issues with its 18A process node and relationships with supply chain partners like TSMC, investor interest has increased. Additionally, Intel's CEO noted strong demand for CPUs for AI workloads and highlighted a new production engagement with Google for an Infrastructure Processing Unit. These developments have contributed to heightened positive sentiment around the stock.

PANW | -3.2% | -2.9B
Palo Alto Networks Inc | Systems Software

Palo Alto Networks Inc's stock has declined in pre-market trading following its fiscal third-quarter results. Although the company reported a revenue increase of 31% year-over-year to $3 billion and beat earnings estimates with an adjusted EPS of $0.85, it also revealed a significant net loss of $177 million compared to a profit of $262 million in the same quarter last year. This mixed financial outcome has overshadowed positive guidance for Q4 revenue and adjusted EPS, which were both above analyst expectations. As a result, retail sentiment has shifted, contributing to a notable decrease in pre-market trading. Earlier this morning, shares dropped as much as -5.76% before recovering slightly, reflecting heightened volatility around the earnings report.

AXSM | +4.1% | +445.3M
Axsome Therapeutics Inc | Pharmaceuticals

Axsome Therapeutics Inc has resolved all patent litigation concerning its product SUNOSI, significantly boosting investor sentiment. The settlement allows five companies to market generic versions of SUNOSI starting in 2040, contingent upon FDA approval, effectively extending Axsome's market exclusivity until that year. This resolution alleviates legal uncertainties surrounding the drug and enables the company to concentrate on its market strategy without ongoing litigation distractions. The news has been well-received, contributing to a sharp increase in the stock price during pre-market hours.

Thank you for spending a minute with us. 

If you have 2 more minutes, watch this demo of the MarketReader Platform: 

Stay in the Loop

Check the MarketReader blog for the latest news, and follow us on X (Twitter) for real-time market insights: @marketreader_AI